Injection Site Local Reactions to Acellular Pertussis Vaccine in children

Injection Site Local Reactions to Acellular Pertussis Vaccine in children - DTaP study in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047780

Enrollment

450

Registered

2022-06-01

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis, Diphtheria, Tetanus

Interventions

DTaP vaccination to the upper arm. DTaP vaccination to the thigh.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 4-6 year-old children, 11-13 year-old adolescents, Any age of adult health care workers

Exclusion criteria

Exclusion criteria: 1) Those who have been vaccinated with DTaP, DTaP-IPV, DT, Tdap within 6 months 2) Those who have received a total of 5 or more doses of DTaP, DTaP-IPV, DT, and Tdap vaccines 3) Contraindicated cases to DTaP vaccine 4) Pregnant women

Design outcomes

Primary

Measure	Time frame
Local reactions by each injection site during 14 days after DTaP vaccination.	—

Countries

Japan

Contacts

Public ContactTomohiro Katsuta

St. Marianna University School of Medicine Department of pediatrics

katsuta-7-@marianna-u.ac.jp+81449778111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026